Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

75results about How to "Reduce bleeding risk" patented technology

Conotoxin-derived anticoagulant polypeptide Cb-13 and application thereof

The invention provides conotoxin-derived anticoagulant polypeptide Cb-13 and application thereof, and belongs to the technical field of biological medicine. The invention provides an anticoagulant polypeptide Cb-13. The amino acid sequence of the anticoagulant polypeptide Cb-13 comprises SEQ ID No.1. The invention also provides a coding gene of the anticoagulant polypeptide Cb-13, and provides that the anticoagulant polypeptide Cb-13 does not have hemolytic activity and does not have cytotoxicity when the concentration is 400 [mu] M or below. The anticoagulant polypeptide Cb-13 disclosed by the invention has a prolonging effect on plasma recalcification and coagulation time, has an anticoagulant effect, has small influence on bleeding, and also has an obvious promoting effect on plasmin and uPa. Meanwhile, it is also proved that the anticoagulant polypeptide Cb-13 can inhibit thrombus formation, that is, the anticoagulant polypeptide Cb-13 has in-vivo and in-vitro fibrinolytic effect and anticoagulant effect, has small bleeding risk, and can be used as an antithrombotic or thrombolytic drug.
Owner:ANHUI UNIV +1

Electric continuous rotary cutting system for laser excision of myocardium

The invention discloses an electric continuous laser excision myocardial rotary cutting system which is characterized in that a target tissue is adsorbed at a rotary cutting window under the suction force of negative pressure, then a puncture needle instantly punctures the tissue under the control of an electronic control assembly, and a target entering an inner cavity of an axial laser rotation excision assembly is punctured and fixed; at the moment, the laser excision knife emits a laser energy column, the laser energy column and the locked tissue needing to be excided rotate by 180 degrees in the axial direction of the puncture needle, the tissue is excided, the laser energy column is reset after being closed, finally, a flange plate of the tissue compression device assembly pushes the cut tissue along the puncture needle to be compressed to a tissue storage bin, and the flange plate is reset; the next round of excision work is prepared after the puncture needle is reset; under the minimally invasive incision state, tissue locking, continuous laser type rotary cutting, automatic tissue compression and storage and accurate cardiac muscle tissue excision can be achieved, tissue wounds can stop bleeding immediately and be solidified, and the risk of excessive loss of blood is reduced.
Owner:YINGTEMU WUHAN MEDICAL TECH CO LTD

Mechanical rotary-cut myocardial resection system with inverted puncture needle

When a rotary cutting device assembly extends into a tissue needing to be operated, a negative pressure device assembly is started, then a trigger is manually pulled, the trigger drives a hinge to move, the hinge drives a rack to move, the rack drives a second bevel gear to move, and the second bevel gear drives the rotary cutting device assembly to rotate. The second bevel gear is in linkage with the first bevel gear to rotate by a preset angle so that the rotary cutting window can be opened, after the tissue is adsorbed into the rotary cutting window, the puncture needle punctures the tissue instantly under the release of the trigger and the limiting pin, a target entering the cavity from the rotary cutting window is punctured and fixed, the trigger continues to be pulled till the bottom is reached, and the second bevel gear is in linkage with the first bevel gear. Rotating the rotary cutting blade to cut off the target tissue; according to the invention, in a minimally invasive incision state, tissue locking, continuous mechanical rotary cutting and accurate cardiac muscle tissue excision can be realized.
Owner:YINGTEMU WUHAN MEDICAL TECH CO LTD

Blood taking needle with negative pressure blood taking tube

The utility model discloses a blood taking needle with a negative pressure blood taking tube, which is characterized in that one end of a push rod far away from a push plate is fixedly connected with a negative pressure plate, the upper surface of the negative pressure tube is movably connected with a connector, the upper surface of the connector is fixedly connected with a hose, and the hose is movably connected with the negative pressure tube. An air bag is arranged on the first connecting pipe, a one-way valve is fixedly connected to the end, away from the fixing pipe, of the first connecting pipe, a hemostasis valve is fixedly connected to the end, away from the fixing pipe, of the second connecting pipe, and through cooperation of the hemostasis valve, the air bag and the one-way valve, after blood sampling is completed, the negative pressure state can be extracted in time; the internal air pressure is smaller than the external air pressure to form an internal and external pressure difference, so that blood cannot flow back; the negative pressure tube is matched with the push rod and the negative pressure plate, the blood sampling amount can be controlled by controlling the negative pressure difference value, and the effects of reducing pain and bleeding risks and improving the blood sampling efficiency are achieved.
Owner:SHANDONG AOSAITE MEDICAL DEVICES CO LTD

Myocardial rotary cutting system with inverted puncture needle

The invention discloses a myocardial rotary cutting system with an inverted puncture needle. The myocardial rotary cutting system comprises a shell, and a rotary cutting device assembly and a negative pressure device assembly are arranged in the shell; the rotary cutting device assembly extends out of the shell, and an inner cavity of the rotary cutting device assembly communicates with an inner cavity of the shell. The side face, away from the shell, of the rotary cutting device assembly is provided with an excision window and a tissue storage chamber, the excision window communicates with an inner cavity of the rotary cutting device assembly, a rotary cutting pipe is arranged in the rotary cutting device assembly, one end of the rotary cutting pipe is connected with a first bevel gear, and a rotary cutting blade is formed at the other end of the rotary cutting pipe. The rotary cutting blade can form continuous axial cutting action relative to the cutting window based on axial rotation; when the rotary cutting pipe shields the cutting window, the cutting window is in a closed state; a puncture needle is arranged in the rotary cutting pipe, and a boss-shaped barb structure is arranged on the puncture needle in a sleeving manner; according to the invention, in a minimally invasive incision state, tissue locking, continuous mechanical rotary cutting and accurate cardiac muscle tissue excision can be realized.
Owner:YINGTEMU WUHAN MEDICAL TECH CO LTD

Computer-assisted drug screening method, system or equipment based on PARP-1 and PAD4

PendingCN119673267AEfficient screening methodThe screening method is accurateInstrumentsMolecular structuresNew medicationsPharmacy medicine
The invention belongs to the technical field of computer-aided drug screening, discloses a computer-aided drug screening method, system or equipment based on PARP-1 and PAD4, and provides a screening method, system and equipment for screening anti-lung cancer thrombosis drugs based on PARP-1 and PAD4 and a computer readable storage medium for the field for the first time. The invention provides an efficient, accurate and rapid screening method for research and development of new drugs for resisting lung cancer thrombosis, and provides a new research direction and strategy for development of new drugs for reducing tumor thrombosis without increasing bleeding risk.
Owner:XUZHOU MEDICAL UNIVERSITY

An artificial blood vessel that is resistant to bending and can be punctured at will

The present invention provides an artificial blood vessel that is resistant to bending and can be punctured at will. The artificial blood vessel includes a blood vessel wall and a blood vessel cavity; according to the radial outward direction of the blood vessel cavity, the blood vessel wall includes a blood vessel wall inner layer, a blood vessel wall middle layer and a blood vessel wall outer layer that are sequentially connected in a bonded manner; the blood vessel wall middle layer includes a puncturable support layer with a grid structure; the puncturable support layer includes a support rib trunk and branch lines extending from the side surface of the support rib trunk and side branches extending from the branch line surface. The artificial blood vessel is provided with a silica gel or polyurethane grid structure in the middle layer, so that the support rib trunk has the performance of being puncturable at will, and the bending resistance of the tube body is improved, and the effective puncture area of ​​the tube body is increased; the grid structure in the middle layer of the blood vessel wall can provide the blood vessel wall with automatic pinhole closing performance through the mutual auxiliary pulling effect of the support rib trunk, branch lines and side branches, thereby reducing the risk of blood leakage in the blood vessel wall after the puncture needle is pulled out.
Owner:SHANGHAI POLLAGEN MEDICAL MATERIALS CO LTD

Atherosclerosis excision device

The invention belongs to the technical field of medical instruments, and particularly relates to an atherosclerosis resection device which comprises a puncture cannula, a shell is in threaded connection with the interior of the puncture cannula, a connecting pipe A is fixedly connected to one end of the shell, and a hole fixedly connected with the cannula is formed in the outer surface of the connecting pipe A; the interior of the sleeve is in threaded connection with a collecting component, and one end of the connecting pipe A is fixedly connected with a connecting pipe B; by means of the collecting component arranged in cooperation with the structure, after the artery plaque is cut up, the artery plaque needs to be removed from the blood vessel, after being removed, the artery plaque is placed in the collecting component, and assemblies in the collecting component can filter the artery plaque and conduct dry-wet separation; the separated artery plaque can be subjected to more detailed pathological and biochemical analysis, composition and characteristics of the plaque can be known, and damage to surrounding tissues in the operation process can be reduced by grinding the plaque and collecting the plaque in a sealed mode.
Owner:NANJING DRUM TOWER HOSPITAL +1

Electric continuous spiral resection type myocardial rotary cutting system

The invention discloses an electric continuous spiral excision type myocardial rotary cutting system which comprises an axial spiral excision knife assembly, a tissue storage bin, a shell, an electronic control assembly, a negative pressure assembly, a spiral knife driving assembly, a protective sleeve driving assembly and a power battery. An axial spiral excision knife assembly in the system can movably stretch into tissue needing to be operated, target tissue entering an inner cavity of the axial spiral excision knife assembly from an excision window can be locked, and then a spiral rotary cutter is driven to rotate under program control of an electronic control assembly. The spiral cutter driving assembly drives the spiral rotary cutter to rapidly rotate clockwise to perform rotary cutting on the target tissue; as the spiral rotary cutter rotates spirally, the cut tissue is pushed to the tissue storage bin along the spiral cavity; therefore, the system disclosed by the invention can realize locking, continuous spiral rotary cutting, automatic compression and storage of tissues and accurate excision of myocardial tissues in a minimally invasive incision state.
Owner:YINGTEMU WUHAN MEDICAL TECH CO LTD

Anti-bending artificial blood vessel capable of being punctured at will

ActiveCN119033501AImprove bending resistanceIncrease effective puncture areaBlood vesselsAnatomyVascular prosthesis
The invention provides an anti-bending artificial blood vessel capable of being punctured at will. The artificial blood vessel comprises a blood vessel wall and a blood vessel cavity; according to the radial outward direction of the blood vessel cavity, the blood vessel wall comprises a blood vessel wall inner layer, a blood vessel wall middle layer and a blood vessel wall outer layer which are sequentially attached and connected; the blood vessel wall middle layer comprises a puncturable supporting layer with a grid structure; the puncturable supporting layer comprises a supporting rib main body, a branch line extending from the side surface of the supporting rib main body and a side branch line extending from the surface of the branch line. According to the artificial blood vessel, the silica gel or polyurethane grid structure is arranged on the middle layer, so that the supporting rib trunk has the performance of being punctured at will, the bending resistance of the vessel body is improved, and the effective puncture area of the vessel body is increased; the grid structure of the middle layer of the blood vessel wall can provide automatic needle hole closing performance for the blood vessel wall through the mutual auxiliary traction effect of the supporting rib trunk, the supporting rib branch lines and the supporting rib side branch lines, and the blood leakage risk of the blood vessel wall after the puncture needle is pulled out is reduced.
Owner:SHANGHAI POLLAGEN MEDICAL MATERIALS CO LTD

Myocardial resection device

The invention belongs to the technical field of medical instruments, and particularly relates to a myocardial resection device which comprises a shell, a groove A is formed in the outer surface of the shell, a measuring assembly is rotationally connected to the inner side wall of the groove A through a rotating rod, a threaded hole in threaded connection with a protective shell is formed in one end of the shell, and a resection assembly is fixedly connected to the inner side wall of the protective shell. The two sides of the shell are fixedly connected with expansion assemblies. By means of the arranged expansion assembly, a better operation visual field can be obtained by expanding the thoracic cavity, a surgeon can conveniently observe and operate the heart and the surrounding structure, compression on the heart and great blood vessels can be reduced by expanding the thoracic cavity, and therefore the risk of damage to tissue in the operation process is reduced; the thoracic cavity clamping device is simple in structure and convenient to use, firmness during clamping expansion can be improved, and the situation that in the cardiac resection operation, the thoracic cavity is not firmly clamped and loosened, consequently, the thoracic cavity is closed again, personnel operation is affected, and medical accidents are likely to happen is avoided.
Owner:NANJING DRUM TOWER HOSPITAL +1

Chimeric gene engineering nano vesicle for removing pathogenic antibody as well as preparation method and application of chimeric gene engineering nano vesicle

PendingCN119120376AMake up for the shortcomings of weak binding abilityImprove adsorption capacityPeptide/protein ingredientsAntipyreticCell membraneBiological safety
The invention discloses a chimeric gene engineering nano vesicle for removing pathogenic antibodies as well as a preparation method and application of the chimeric gene engineering nano vesicle, and belongs to the technical field of biology. According to the invention, a stable transfection cell line of a protein A / G gene is constructed through lentiviral particle transfection, so that the protein A and the protein G can be stably expressed. The fusion protein A / G can overcome the defect of weak binding capacity of pure protein A and IgG3, and the adsorption effect of the antibody IgG is improved. The PLGA nanoparticles with relatively uniform particle size are adopted as the core of the target vesicle and are mixed with the engineered cell membrane broken by extrusion to promote self-assembly of the cell membrane and form an extracellular vesicle simulant, so that the stability of the target nano vesicle is improved. The prepared and separated nano vesicles can be applied to in-vivo adsorption and antibody removal, the biological safety is good, and the dialysis indwelling catheter operation risk in the use process of an existing immunoadsorption column and the risks of bleeding, allergy and the like in the treatment process are avoided.
Owner:THE FIRST AFFILIATED HOSPITAL ZHEJIANG UNIV COLLEGE OF MEDICINE

Polypeptide modified liposome as well as preparation method and application thereof

The invention provides a polypeptide modified liposome as well as a preparation method and application thereof, and belongs to the technical field of biological medicines. The polypeptide modified liposome consists of phospholipid, polypeptide modified phospholipid and auxiliary phospholipid, the molar ratio of the phospholipid to the polypeptide modified phospholipid to the auxiliary phospholipid is 20: (1-15): (1-10). Connecting the polypeptide with phospholipid to obtain polypeptide modified phospholipid; mixing phospholipid, polypeptide modified phospholipid and auxiliary phospholipid, and dissolving in an organic solvent; evaporating the organic solvent to form a phospholipid bilayer; and hydrating, centrifuging and collecting to obtain the polypeptide modified liposome. The nano-scale polypeptide modified liposome has good stability and biocompatibility, heparin is uniformly distributed on the surface of the cationic liposome through electrostatic attraction to realize high-stability combination, the anticoagulant activity of heparin drugs UFH, LMWHs and Fonda can be quickly reversed, the bleeding risk of a patient is effectively reduced, and the application prospect is broad. Meanwhile, a serious immunogenicity reaction is not caused.
Owner:UNIV OF CHINESE ACAD OF SCI

A ventricular assist device that can be used for ventricular aneurysm

ActiveCN118105114Breduce the risk of blood clotsFast deformationSurgeryVentricular aneurysmVentricular assistance
A ventricular assist device that can be used for ventricular aneurysm includes a stent, the stent having a first end and a second end opposite to each other, a polymer film attached to the first end of the stent, a base provided at the second end of the stent, and a force-bearing portion formed between the first end and the second end of the stent, which can spontaneously adapt to the contraction and relaxation movements of the heart. That is, when the force-bearing portion contracts radially under force, the stent stretches axially; when the external force disappears and the force-bearing portion is not radially stressed, the stent returns to its original state. A skirt is provided at the edge of the polymer film, and one end of the skirt away from the polymer film is reversely adhered to the polymer film. When the stent enters the ventricle, the portion of the skirt that is reversely adhered to the polymer film is separated from the polymer film and adsorbed to the ventricular cavity wall, thereby reducing or even solving the problem of residual leakage after surgery.
Owner:FOURTH MILITARY MEDICAL UNIVERSITY

Burn wound eschar abrading device for surgical debridement

The invention discloses a burn wound eschar abrading device for surgical debridement, which relates to the technical field of eschar abrading devices and comprises a shell, an arc eschar abrading surface fixed at the bottom of the shell, a motor arranged at the top of the shell and a partition plate fixedly connected in the shell. The scab abrading tool bit is exposed out of the scab abrading face and can adjust the contraction angle of the tool bit in a self-adaptive mode, the oil pressure control assembly contracts the scab abrading tool bit in a self-adaptive mode based on the radian of the wound scab, the scab abrading driving structure starts and stops rotation of the scab abrading tool bit through the oil pressure control assembly, and the dust collection assembly is fixed to the center of the bottom of the partition plate. The eschar abrading tool bits are distributed in the circular array and rotate oppositely in pairs, the rotating directions of the opposite eschar abrading tool bits are opposite, the eschar abrading tool bits counteract and reduce shaking of the skin and the wound eschar in the friction direction of the eschar abrading tool bits, continuous tearing between the wound eschar and skin tissue is effectively avoided, and the healing effect of the skin is improved. And the discomfort of the patient and the risk of secondary injury of the wound surface caused by tearing the connection between the wound surface scab and the tissue due to high-speed shaking are reduced.
Owner:JIANGSU TAIZHOU PEOPLES HOSPITAL

Nipple cutting balloon dilation catheter

The utility model provides a kind of nipple cutting balloon dilatation catheter, comprising: the balloon part of being arranged in the front part of catheter, the tube wall of the balloon part is wrapped with balloon, the outer surface of the balloon is equipped with multiple knife filaments, and the knife filament is used to be connected with high frequency generator.The utility model can be sent into or pulled out duodenal nipple in the guide of guide wire, and dilate duodenal nipple, when nipple sphincter stenosis appears, handle joint connects high frequency generator, and the knife filament on the surface of balloon can carry out electroincision effect to the tissue of stenosis, increase stenosis dilatation efficiency and effect.
Owner:SHANGHAI RUIFAN MEDICAL TECHNOLOGY CO LTD

Peeling composition for digestive endoscopy minimally invasive surgery

The invention discloses a stripping composition for digestive endoscopic minimally invasive surgery, which is prepared from the following components in parts by weight: 5 to 10 parts of tissue stripping agent, 0.5 to 1.0 part of osmotic pressure regulator, 0.01 to 0.2 part of synergist, 0.01 to 0.1 part of stabilizer, 0.001 to 0.1 part of hemostatic and 0.0005 to 0.002 part of color indicator. By dissolving connective tissues under the mucous membrane, the time for stripping by using an electrotome is shortened, the surgical stripping difficulty is reduced, the surgical time is shortened, the risks of bleeding and perforation in the surgical process and postoperation delayed bleeding and perforation are reduced, and the safety is improved.
Owner:FUJIAN CANCER HOSPITAL (FUJIAN CANCER INST FUJIAN CANCER PREVENTION & CONTROL CENT)

Puncture point compressor for far-end radial artery

The utility model relates to a compressor for a far-end radial artery puncture point, which comprises a fixed base, an elastic fixing band, a finger binding band and a pressurizing component, and is characterized in that the middle positions of the two ends of the fixed base respectively extend outwards to form fixing lugs; correspondingly, long holes are formed in the fixing lugs at the two ends in a penetrating mode; an elastic fixing belt and a finger binding belt are arranged in the long holes of the fixing lugs in a sleeved mode respectively. A threaded hole is formed in the middle of the fixed base, and a pressurizing assembly is further in threaded connection with the interior of the threaded hole. The compression hemostasis device has the advantages that the shape of a human hand can be combined according to a puncture part, the spiral rod can be rotated and twisted through matching of the elastic fixing band and the finger binding band, pressure is applied to the rubber compression block to compress a puncture point, and the ideal compression hemostasis effect is achieved; the problems that the wound position cannot be accurately pressed due to traditional bandage bundling hemostasis, the patient feels uncomfortable due to the large hand pressing area of the patient are solved, operation is easy and convenient, and the hemostasis condition can be conveniently observed in real time.
Owner:THE FIRST AFFILIATED HOSPITAL OF NAVAL MEDICAL UNIVERSITY OF CHINESE PEOPLES LIBERATION ARMY

A pharmaceutical composition for treating acute ischemic stroke and use thereof

PendingCN122272778AEnhance recanalization stabilityStrong specificityBlood flowDepressant
This invention relates to a pharmaceutical composition and its application for treating acute ischemic stroke. The pharmaceutical composition for treating acute ischemic stroke comprises separately packaged tissue-type plasminogen activator citPA5 and a platelet aggregation inhibitor. Its beneficial effects include significantly improving cerebral blood flow recovery, shortening thrombolysis time, reducing infarct volume, and improving neurological function without increasing the risk of bleeding, demonstrating a good synergistic thrombolytic effect.
Owner:FUZHOU UNIV

Use of plantain fruit extract in preparation of anticoagulant or antithrombotic drugs

PendingCN122272702AHas anti-inflammatory propertiesHas antioxidant propertiesPlatelet inhibitionFlavonoid
This invention relates to the field of biomedicine, specifically to the application of banana fruit extract in the preparation of anticoagulant or antithrombotic drugs. The banana fruit extract provided by this invention contains flavonoids, polyphenols, polysaccharides, hydroxyanthraquinones, triterpenoids, and other components. Flavonoids and polyphenols have been widely proven to have anti-inflammatory and antioxidant effects, which can synergistically enhance the anticoagulant effect. The high potassium content of banana fruit can indirectly improve vascular function by regulating sodium-potassium balance. The banana fruit extract provided by this invention can inhibit platelet production or promote platelet metabolism, prolong clotting time, and inhibit platelet aggregation. Its natural plant components interfere with platelet aggregation by inhibiting the production of thromboxane A2, achieving anticoagulant and antithrombotic effects. The mechanism of action of banana fruit extract differs from traditional anticoagulants such as heparin, reducing the risk of bleeding. Its natural component characteristics provide a direction for the development of novel plant-derived anticoagulant drugs.
Owner:GUANGXI XIUPEI KELING BIOTECHNOLOGY CO LTD

A production process of three-sided gold-plated gold finger

ActiveCN115955786BAffect the conductive effectaffect quality
The application discloses a production process of a three-breaded gold-plated gold finger, which is connected to the front end of the gold finger in the form of outer pull lead + silk screen wet film, makes the gold finger conductive with the whole PCB board surface, completes the production of the gold-plated gold finger in the form of electroplated nickel gold, then etches off the lead, and then carries out the production of the post-process; the main key points of the process are as follows: the quality of the silk screen wet film, the temperature and time of pre-baking, the exposure energy, the parameters during the plating of the gold finger, and the quality during the etching of the lead; the production process is simple and easy to implement, optimizes the production process of the three-breaded gold-plated gold finger, solves the lead residue caused by the traditional hand tearing lead process and the abnormal plating caused by the dry film pressing or blue glue pressing process, and the produced gold finger has better operability, higher yield and better quality, and can be mass-produced.
Owner:YIXING SILICON VALLEY ELECTRONICS TECH

Posterior implant placement plan needle path optimization method and apparatus

The application provides a method and equipment for optimizing a needle channel of a postoperative implantation plan. The method comprises the following steps: S1, constructing a three-dimensional coordinate system of an object based on CT or MRI images, and reconstructing three-dimensional space information of PTV and OAR; S2, setting a surface needle insertion surface position and range of the object in the three-dimensional coordinate system of the object, calculating all needle paths according to the three-dimensional spatial position relationship of PTV and OAR, combining the needle size and the physical restriction condition between the needle channels; S3, defining a penalty function model, calculating the position relationship between the prescription dose line and PTV and OAR in the three-dimensional space according to the dose distribution and the attenuation characteristics of the radiation source, and generating the penalty function model; S4, defining the number of needles, calculating the penalty function values of different needle number combinations, and taking the needle combination and path corresponding to the minimum function value as the optimal scheme. The application can reduce the normal tissue damage of implantation treatment and improve the efficiency and curative effect.
Owner:ZHONGNAN HOSPITAL OF WUHAN UNIV

Bellyband type sandbag sleeve

The utility model relates to the technical field of delivery supplies, in particular to a bellyband type sandbag sleeve which comprises a bandage, a first hook-and-loop fastener is mounted at one end of the bandage, a first loop-side hook-and-loop fastener is mounted at the other end of the bandage, the bandage is transversely bound to the waist of a patient, and the end of the bandage is fixedly connected with the first loop-side hook-and-loop fastener through the first hook-and-loop fastener. The middle of the bandage is connected with a first placing bag, and the upper portion of the bandage is connected with a second placing bag. According to the bellyband type sandbag sleeve, stable fixation and effective compression of the sandbag on the belly wound and the bottom of the uterine opening of a patient are achieved, and the nursing effect after delivery is remarkably improved. Specifically, according to the bellyband type sandbag sleeve, the combination of the binding bands and the hook-and-loop fasteners is adopted, so that the bellyband can be transversely bound to the waist of a patient, and rapid and firm fixation is achieved through the cooperation of the first thorn face hook-and-loop fasteners and the first loop face hook-and-loop fasteners. The fixing mode is easy and convenient to operate, flexible adjustment can be conducted according to the waistline of the patient, and using comfort and applicability are improved.
Owner:THE FIRST HOSPITAL OF NANPING CITY FUJIAN PROVINCE

Application of nicotinamide adenine dinucleotide in preparation of antiplatelet drugs

The invention relates to the field of biological medicines, and discloses application of nicotinamide adenine dinucleotide in preparation of an anti-platelet medicine, and discloses the anti-platelet medicine which contains a therapeutically effective amount of nicotinamide adenine dinucleotide as a unique active ingredient, or the medicine is a medicine composition, or the medicine composition is a medicine composition or an anti-platelet medicine composition or an anti-platelet medicine composition or an anti-platelet medicine composition or an anti-platelet medicine composition or an anti-platelet medicine composition or an anti-platelet medicine composition. In addition to a therapeutically effective amount of nicotinamide adenine dinucleotide as an active ingredient, the pharmaceutical composition also contains other anti-platelet pharmaceutical ingredients. The medicine can be used for preventing or treating arterial thrombotic diseases such as coronary heart disease, myocardial infarction or cerebral apoplexy, and has clinical application and development prospects.
Owner:ZHONGSHAN HOSPITAL FUDAN UNIV

Single-crystal magnesium alloy wire for losing weight by embedding catguts in acupoints and preparation method of single-crystal magnesium alloy wire

The invention discloses a single-crystal magnesium alloy wire for acupoint catgut embedding and weight losing and a preparation method of the single-crystal magnesium alloy wire, the chemical composition expression of the single-crystal magnesium alloy wire is Mg-yM-zR, in the formula, y and z represent the mass fraction of M and the mass fraction of R in magnesium alloy respectively, y is larger than or equal to 1.2 and smaller than or equal to 1.7, z is larger than or equal to 0.3 and smaller than or equal to 0.8, and the balance is Mg; m is one of Sr, Ce and Co, and R is one of Ge, Sm and Dy; the wire is prepared through the processes of smelting and casting, homogenizing treatment, hot extrusion, multi-pass cold drawing, intermediate annealing and zone smelting and directional solidification, and has uniform and controllable degradation rate, excellent mechanical property and biocompatibility; after the catgut embedding slimming agent is embedded into the acupuncture point of a human body, fat metabolism is promoted through mild and lasting physical stimulation and chemical ion regulation, intergranular corrosion and premature fracture caused by a polycrystalline structure are avoided, and the safety and durability of a catgut embedding slimming therapy are improved.
Owner:YANSHAN UNIV

Peel expanding device adopting blunt separation method

The utility model discloses a skin expanding device adopting a blunt separation method, which belongs to the technical field of minimally invasive surgery and comprises a blunt separation handle, a thick flaring needle and a thin flaring needle. The thick flaring needle is detachably connected with the blunt separation handle; the fine flaring needle is detachably connected with the blunt separation handle; the thick flaring needle and the thin flaring needle are located on the upper side and the lower side of the blunt separation handle respectively. The thick flaring needle, the thin flaring needle and the blunt separation handle are respectively provided with a through guide wire channel. The skin expanding device adopting the blunt separation method has the advantages that a puncture opening does not need to be cut and expanded again, and secondary damage to the puncture opening is avoided.
Owner:ZHEJIANG PROVINCIAL PEOPLES HOSPITAL

Liver cirrhosis acute variceal bleeding ai treatment decision system

ActiveCN120412909Breduce bleeding riskAdjust Healing IntensityInitial treatmentPortal vein flow
The application provides an AI treatment decision system for liver cirrhosis acute variceal hemorrhage, relates to the technical field of treatment decision, extracts a transient characteristic indicator of blood flow pressure from a pressure fluctuation signal, predicts a transient pressure peak of the portal vein blood flow during acute variceal hemorrhage through the transient characteristic indicator and a blood flow dynamic model, predicts a quasi-steady pressure field of the portal vein blood flow during acute variceal hemorrhage according to the gradient distribution of the portal vein blood flow pressure and an initial treatment strategy of acute variceal hemorrhage, performs multi-scale coupling on the transient pressure peak and the quasi-steady pressure field to obtain a coupling characteristic of the portal vein blood flow, and then uses the coupling characteristic of the blood flow pressure to perform hierarchical coupling adjustment on the treatment strategy of liver cirrhosis acute variceal hemorrhage. Based on the above scheme, hierarchical coupling of the treatment strategy of liver cirrhosis acute variceal hemorrhage can be realized, so that the prediction accuracy of the portal vein blood flow pressure during acute variceal hemorrhage can be improved.
Owner:SHENZHEN JIMI RESEARCH CO LTD

Balloon catheter integrating lung biopsy and hemostasis through bronchoscope freezing

The invention relates to a bronchoscope frozen lung biopsy and hemostasis integrated balloon catheter, belongs to the technical field of medical instruments, and solves the problems that in the prior art, operation steps are complicated and difficult, and a biopsy sample of a lung tip part is accurately obtained. The bronchoscope frozen lung biopsy and hemostasis integrated balloon catheter comprises a catheter body, wherein the catheter body is provided with a catheter head end and a catheter tail end; a working hole channel, a balloon channel and a guide wire channel which are independent from one another are integrated on the catheter main body; the working hole channel is configured as a channel when the freezing probe performs biopsy operation and is used for spraying a hemostatic medicine to a hemostatic part in an airway; a medicine balloon is arranged at the head end of the catheter, hemostatic particles are arranged on the outer surface of the medicine balloon, and the medicine balloon is communicated with the balloon channel and is configured to be inflated to expand the medicine balloon to achieve compression hemostasis; and a guide wire is arranged in the guide wire channel and is configured to guide the catheter main body to a target position. According to the application, the functions of freezing biopsy and instant hemostasis are integrated.
Owner:FUWAI HOSPITAL CHINESE ACAD OF MEDICAL SCI & PEKING UNION MEDICAL COLLEGE

Tirofiban-carried bovine serum albumin nanoparticles as well as preparation method and application thereof

PendingCN118975988Aquick releaseInhibitionOrganic active ingredientsPowder deliveryPostoperative myocardial infarctionCytotoxicity
The invention relates to the technical field of biological materials, and discloses a tirofiban-carrying bovine serum albumin nanoparticle and a preparation method and application thereof, and the tirofiban-carrying bovine serum albumin nanoparticle comprises tirofiban and bovine serum albumin; the mass ratio of the tirofiban to the bovine serum albumin is (0.25-1.0): (8-12). The bovine serum albumin nanoparticles carrying tirofiban can locally act on transplanted veins in a targeting manner, early-stage drug release is fast, cytotoxicity is avoided, platelet resistance can be achieved, the dual purposes of PMI generation inhibition and bleeding risk reduction can be achieved, local targeting drug release can be more efficiently and safely carried out, and the application prospect is wide. The occurrence of postoperative myocardial infarction can be effectively avoided.
Owner:BEIJING ANZHEN HOSPITAL AFFILIATED TO CAPITAL MEDICAL UNIV